Quantum-Si (NASDAQ:QSI) Stock Price Down 0.5% – Here’s What Happened

Quantum-Si Incorporated (NASDAQ:QSI) shares dropped 0.5% during trading on Wednesday . The stock traded as low as $0.86 and last traded at $0.8620. 2,249,786 shares traded hands during mid-day trading, a decline of 51% from the average session volume of 4,623,178 shares. The stock had previously closed at $0.8662.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Quantum-Si has a consensus rating of “Reduce” and a consensus price target of $1.00.

Quantum-Si Stock Up 0.6%

The company has a market capitalization of $179.43 million, a PE ratio of -1.62 and a beta of 3.20. The firm’s 50 day simple moving average is $0.97 and its 200 day simple moving average is $0.99.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.02. Quantum-Si had a negative net margin of 5,605.88% and a negative return on equity of 47.35%. The firm had revenue of $0.26 million during the quarter, compared to analyst estimates of $0.30 million. As a group, sell-side analysts predict that Quantum-Si Incorporated will post -0.49 EPS for the current fiscal year.

Insider Activity at Quantum-Si

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 83,712 shares of the business’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $1.01, for a total transaction of $84,549.12. Following the completion of the transaction, the chief executive officer owned 3,776,135 shares in the company, valued at $3,813,896.35. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jeffry R. Keyes sold 37,382 shares of the stock in a transaction on Monday, April 20th. The stock was sold at an average price of $1.01, for a total value of $37,755.82. Following the completion of the sale, the chief financial officer owned 1,769,963 shares in the company, valued at approximately $1,787,662.63. The trade was a 2.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 219,552 shares of company stock valued at $216,114 in the last 90 days. Company insiders own 22.04% of the company’s stock.

Institutional Investors Weigh In On Quantum-Si

Several large investors have recently added to or reduced their stakes in the stock. Prudential Financial Inc. purchased a new position in shares of Quantum-Si during the second quarter worth approximately $25,000. Curbstone Financial Management Corp purchased a new stake in shares of Quantum-Si in the fourth quarter valued at approximately $26,000. Leonteq Securities AG purchased a new stake in shares of Quantum-Si in the fourth quarter valued at approximately $28,000. Cerity Partners LLC bought a new position in Quantum-Si in the second quarter worth approximately $29,000. Finally, Hollencrest Capital Management grew its stake in Quantum-Si by 301.1% in the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock worth $31,000 after purchasing an additional 30,111 shares in the last quarter. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.